blue cross blue shield federal glp 1 coverage Weight fep blue cross blue shield

Interestingly, studies examining placental passage of exenatide and liraglutide in human cases suggest minimal to no fetal exposure shortly after administration, indicating that maternal metabolic effects, rather than direct fetal exposure, may contribute to adverse outcomes

This matters particularly during cold winter months when extended transit could subject peptides to temperature extremes

Advertisement Most people feel better within 48 hours of treatment

May support insulin sensitivity, oxidative stress balance and metabolic health

If severe side effects occur, your provider might extend the time at your current dose or even temporarily lower it